Purdue Pharma settlement draws skepticism; troubling questions of Prop 22 and 501c4 status; AbilityOne should be phased out, disability advocates say
Purdue Pharma settlement draws skepticism; troubling questions of Prop 22 and 501c4 status; AbilityOne should be phased out, disability advocates say; and more!
A May 2020 Census Bureau poll found one-third of Americans are exhibiting signs of clinical anxiety or depression, and healthcare workers are taking the brunt of this exposure, bearing witness to immense uncertainty, trauma, tragedy, and loss of human life. Having patients die may be a reality of care work, but the scale in 2020 is extraordinary.
How will we care for those who care for us? It’s a vital question to consider as COVID-19’s death toll continues and creates a high PTSD risk for caregivers.
Improve Your Dashboards. Improve Decision-Making. Where are you in the Dashboard lifecycle? This White Paper offers tips, tools, worksheets and guidelines to improve your dashboard's effectiveness.
The guilty plea and settlement reached by the Justice Department and Purdue Pharma is a clear softball move that may be more smoke and mirrors than anything else.
The corporate use of nonprofits to veil their policy influence comes in many varieties, and in the case of Proposition 22, a more central question is called regarding 501c4s.
An antiquated disability employment program is being recommended for phase-out after a report reveals nonprofits seem to be benefitting more than the workers.
At Northwestern, a student-alumni group directly challenged the administration’s attempt to smear those protesting racism with the canard of anti-Semitism.
Some nonprofits, once they figured out how to transition to virtual programming, found the results so promising that they might keep their programs that way permanently.
Nonprofit Leadership Courses & Graduate Program Pursue professional development courses or a graduate credential in Nonprofit Leadership at the University of Denver, a top 100 university dedicated to the public good.
